CODI-PC — Compass Diversified

Summary of CODI-PC Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 2025 GAAP Net Revenue: $468.6 million, down 5.1% year-over-year, primarily due to the impact of Lugano's bankruptcy.
• Q4 2025 GAAP Net Loss: $78.8 million, including over $25 million in one-time costs related to Lugano.
• Full Year 2025 Net Revenue: $1.9 billion, up 4.8%.
• Full Year 2025 GAAP Net Loss: $293.7 million, including approximately $60 million in investigation and restatement costs.
• Non-GAAP Results (excluding Lugano):
  • Net Sales: $1.8 billion, up 3.9%.
  • Subsidiary Adjusted EBITDA: $345.8 million, an increase of 8.8%.
• Cash Position: Ended 2025 with $68 million in cash and $96 million available on the revolver.
• Leverage Ratio: Approximately 5.47x at year-end, slightly higher than anticipated.

2. Strategic Updates and Business Highlights

• Operational Resilience: Despite a challenging year, CODI's subsidiaries showed strong performance, particularly in the consumer segment, which grew adjusted EBITDA by 13.8%.
• Focus on Deleveraging: CODI is prioritizing reducing its leverage ratio through organic growth and potential divestitures of subsidiaries.
• Sale Processes: Multiple sale processes are underway for subsidiaries, with strong interest from both financial and strategic buyers.
• Key Subsidiary Highlights:
  • BOA: Strong performance at the Winter Games, with significant medal wins.
  • The Honey Pot: Established a leading position in feminine care with strong consumer metrics.
  • Arnold: Increased backlog and quoting activity, though facing near-term challenges due to geopolitical issues.

3. Forward Guidance and Outlook

• 2026 Subsidiary Adjusted EBITDA Expectation: $345 million to $395 million, with consumer EBITDA projected between $220 million to $260 million and industrial EBITDA between $125 million to $135 million.
• CapEx for 2026: Expected to be between $30 million to $40 million.
• Free Cash Flow Projection: Anticipated to be between $50 million to $100 million, with potential upside from recoveries related to Lugano.

4. Bad News, Challenges, or Points of Concern

• Impact of Lugano: The bankruptcy of Lugano has significantly affected financial results and contributed to a GAAP net loss.
• Geopolitical Risks: Ongoing trade tensions and export restrictions from China are causing uncertainty, particularly affecting Arnold's operations.
• Consumer Spending Pressure: Tariff-related uncertainties and inflation are impacting consumer behavior, leading to potential volatility in the branded consumer business.
• Weakness in Industrial Segment: Altor is facing challenges due to a slowdown in vaccine-related sales and tariffs affecting appliance purchases.

5. Notable Q&A Insights

• Sale Processes: Management indicated strong interest in the subsidiaries being considered for divestiture, with multiple bidders expected.
• Arnold's Outlook: While facing near-term geopolitical headwinds, Arnold's backlog and quoting activity are at record levels, suggesting potential for recovery in the latter half of 2026.
• Altor's Cautious Outlook: Management expressed caution regarding Altor's performance due to ongoing challenges in the vaccine market and tariffs.
• 5.11 Performance: The professional side of 5.11 is performing well, but the consumer side is struggling due to inflation and price sensitivity.

Overall, while CODI faced significant challenges in 2025, the company is focused on strategic initiatives to improve financial health and operational performance moving into 2026.